Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuraxis (NRXS) EBT Margin (2022 - 2025)

Neuraxis (NRXS) has disclosed EBT Margin for 4 consecutive years, with 180.3% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 1238.0% to 180.3% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 221.44% through Dec 2025, up 5142.0% year-over-year, with the annual reading at 221.44% for FY2025, 6683.0% up from the prior year.
  • EBT Margin hit 180.3% in Q4 2025 for Neuraxis, up from 262.47% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 103.14% in Q2 2022 to a low of 632.89% in Q3 2023.
  • Historically, EBT Margin has averaged 251.87% across 4 years, with a median of 210.71% in 2022.
  • Biggest five-year swings in EBT Margin: crashed -42219bps in 2023 and later surged 37549bps in 2024.
  • Year by year, EBT Margin stood at 186.53% in 2022, then plummeted by -64bps to 305.68% in 2023, then skyrocketed by 37bps to 192.68% in 2024, then rose by 6bps to 180.3% in 2025.
  • Business Quant data shows EBT Margin for NRXS at 180.3% in Q4 2025, 262.47% in Q3 2025, and 193.64% in Q2 2025.